A&B

Alexander & Baldwin Announces First Quarter 2023 Earnings Release and Conference Call Date

Retrieved on: 
Tuesday, April 18, 2023
Webcast, Alexander & Baldwin, ALEX, NYSE, A&B, Alexander, Management

HONOLULU, April 18, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B) will report results for the first quarter 2023, after the market closes, on Thursday, May 4, 2023.

Key Points: 
  • HONOLULU, April 18, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B) will report results for the first quarter 2023, after the market closes, on Thursday, May 4, 2023.
  • In connection with this announcement, A&B will host a conference call and webcast on Thursday, May 4, 2023, at 5:00 p.m.
  • The call and webcast will feature a discussion on first quarter 2023 operating and financial performance, followed by questions from sell-side research analysts participating in the interactive portion of the discussion.
  • Earnings documents will be available for download from A&B's website after the market closes on May 4, 2023.

ALEXANDER & BALDWIN, INC. ANNOUNCES LEADERSHIP TRANSITION

Retrieved on: 
Wednesday, February 1, 2023
Penn State Board of Trustees, NYSE, Acquisition, University, ALEX, Alexander & Baldwin, Growth, A&B, Parker, Management, Property management, Kamehameha Schools

HONOLULU, Feb. 1, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a premier Hawai`i commercial real estate company, today announced that Lance K. Parker, currently A&B's president & chief operating officer (COO), has been appointed the Company's new president & chief executive officer (CEO) effective July 1, 2023.  Parker will succeed CEO Christopher J. Benjamin who will retire on June 30 but serve as a consultant through the end of 2023 to ensure a smooth transition and complete various aspects of A&B's simplification strategy.

Key Points: 
  • "When Chris became CEO, his mandate was to transform A&B from a diversified conglomerate to a focused commercial real estate company.
  • The Board and I appreciate his outstanding leadership over the past seven years."
  • "We have accomplished a great deal in transitioning A&B from a diversified operating business to a focused real estate company.
  • "With a stellar team of real estate experts in place under the leadership of Lance Parker, I am confident in A&B's trajectory as a Hawai`i commercial real estate company."

Alexander & Baldwin Announces Fourth Quarter and Full-Year 2022 Earnings Release and Conference Call Date

Retrieved on: 
Tuesday, January 31, 2023
A&B, Alexander & Baldwin, NYSE, Alexander, ALEX, Webcast, Management

HONOLULU, Jan. 31, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B) will report results for the fourth quarter and full-year 2022, after the market closes, on Tuesday, February 28, 2023.

Key Points: 
  • HONOLULU, Jan. 31, 2023 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B) will report results for the fourth quarter and full-year 2022, after the market closes, on Tuesday, February 28, 2023.
  • In connection with this announcement, A&B will host a conference call and webcast on Tuesday, February 28, 2023, at 5:00 p.m.
  • To listen to the conference call, please dial in at least 5 minutes prior to start time.
  • Please instruct the operator to connect you to the Alexander & Baldwin call.

HEI appoints Paul Ito as Chief Financial Officer

Retrieved on: 
Tuesday, January 3, 2023
A&B, Savings bank, F.S.B, American Savings Bank, CFO, LLP, ALEX, HE, Alexander, HEI, NYSE, Treasury, University of Hawaiʻi, Employment, University, Growth, Alexander & Baldwin, Hawaiian Electric Industries, ASB, Information technology, Financial management, Investment, University of Texas at Austin, North Pacific Current, Management

(ASB), has appointed Paul K. Ito as executive vice president and chief financial officer (CFO), effective January 1, 2023.

Key Points: 
  • (ASB), has appointed Paul K. Ito as executive vice president and chief financial officer (CFO), effective January 1, 2023.
  • Ito was selected following a broad, national search conducted by the HEI leadership team and its board of directors.
  • Ito has been with HEI since 2018, where he has served as vice president of tax, controller and treasurer.
  • Ito also managed HEI's information technology efforts, leading digital transformation initiatives in accounting, tax and financial reporting.

ALEXANDER & BALDWIN PROMOTES LANCE PARKER TO PRESIDENT AND CHIEF OPERATING OFFICER

Retrieved on: 
Monday, December 12, 2022
Partner, Walter B. Parker, Transport, Parker, ALEX, Alexander & Baldwin, NYSE, CRE, Multimedia, University, A&B, Tourism, Penn State Board of Trustees, Acquisition, Management, Kamehameha Schools

HONOLULU, Dec. 12, 2022 /PRNewswire/ --Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a premier Hawai'i commercial real estate company, today announced the appointment of Lance K. Parker, currently the Company's chief operating officer, to the additional position of president, effective January 1, 2023.

Key Points: 
  • HONOLULU, Dec. 12, 2022 /PRNewswire/ --Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a premier Hawai'i commercial real estate company, today announced the appointment of Lance K. Parker, currently the Company's chief operating officer, to the additional position of president, effective January 1, 2023.
  • Christopher J. Benjamin, currently president and chief executive officer, will remain the Company's CEO.
  • He took the helm of A&B's real estate business in 2015 and has been A&B's chief operating officer since November 2021.
  • Born and raised in Hawai'i, Parker began his career in commercial real estate in Southern California before returning to the islands to join the Company.

Alexander & Baldwin to Participate in Sidoti's December 2022 Small-Cap Virtual Conference

Retrieved on: 
Wednesday, December 7, 2022
Alexander & Baldwin, ALEX, NYSE, A&B, Tourism, Webcast, Transport, Conference, CRE, Video game, Sidoti

HONOLULU, Dec. 7, 2022 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE:ALEX) (A&B)announced today that its management team will participate in the Sidoti December 2022 Small-Cap Virtual Conference.

Key Points: 
  • HONOLULU, Dec. 7, 2022 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE:ALEX) (A&B)announced today that its management team will participate in the Sidoti December 2022 Small-Cap Virtual Conference.
  • There will be a live webcast of the Company's presentation on Wednesday, December 7, 2022, from 4:00 p.m. to 4:30 p.m. Eastern Time.
  • Access to the webcast will be available via the following link:
    Investor material for the conference, scheduled for December 78, 2022, may be accessed on the Company's website at www.alexanderbaldwin.com .
  • Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B)is the only publicly-traded real estate investment trust to focus exclusively on Hawai'i commercial real estate and is the state's largest owner of grocery-anchored, neighborhood shopping centers.

Acticor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE, Its Pivotal Phase II/III Study for Registration in Stroke

Retrieved on: 
Monday, December 5, 2022
Health, Research, Pharmaceutical, Science, Cardiology, Biotechnology, Newton, Stroke, Document, Standard of care, CHMP, Intracerebral hemorrhage, Medicine, MAA, Mab, Agency, Centre de documentation de la musique contemporaine, EMA, Patient, Disability, Death, Infarction, ESOC, Regulatory affairs, ISIN, Biotechnology, Rankine scale, Committee, Particle-size distribution, GPVI, European Medicines Agency, Medication, AIS, PRIME, Clinical trial, Safety, A&B, Brain, Mortality, Marketing, VI, Thrombectomy, Committee for Medicinal Products for Human Use, Pharmaceutical industry, Medical imaging, INSERM

The discussion meeting took place remotely in October 2022, and Acticor Biotech provided a list of questions concerning the non-clinical development and the study design of the ACTISAVE study.

Key Points: 
  • The discussion meeting took place remotely in October 2022, and Acticor Biotech provided a list of questions concerning the non-clinical development and the study design of the ACTISAVE study.
  • Although CHMP recommendations were issued to further detail some analyses, the statistical methodology was therefore endorsed on its general principles.
  • In July 2022, Acticor Biotech was granted "PRIME" status by the European Medicines Agency (EMA) for glenzocimab in the treatment of stroke.
  • The forward-looking statements contained in this press release are also subject to risks not yet known to Acticor Biotech or not currently considered material by Acticor Biotech.

Acticor Biotech: World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks

Retrieved on: 
Tuesday, November 22, 2022
Health, Research, Pharmaceutical, Science, Cardiology, Biotechnology, Newton, Clinical trial, CTU, Brain, Survival, University, Centre de documentation de la musique contemporaine, European Medicines Agency, Infarction, STEMI, University Hospitals Birmingham NHS Foundation Trust, Stroke, A&B, BHP, Blood, Medicine, ISIN, Queen Elizabeth Hospital, Degenerative disease, Partnership, Myocardial infarction, ESOC, Mortality, Intracerebral hemorrhage, Clinical trials unit, MI, University of Birmingham, EMA, Document, Angioplasty, Queen Elizabeth Hospital Birmingham (1933–2010), Thrombosis, GPVI, Therapy, Mab, Hospital, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Northern General Hospital, VI, Associate, Heart, Patient, Medical device, Pharmaceutical industry, INSERM, Cardiology

Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.

Key Points: 
  • Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
  • A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK.
  • Although immediate opening of the blocked coronary artery by angioplasty in cases of heart attack is now routine, significant heart damage still occurs.
  • Were delighted to work with Acticor to see whether this new class of drug has the potential to improve the outcomes of our patients with heart attacks.

Alexander & Baldwin to Participate in Nareit's REITworld 2022 Annual Conference

Retrieved on: 
Tuesday, November 15, 2022
Company, CRE, ALEX, A&B, NYSE, Alexander & Baldwin, Conference, Tourism, Transport, Commercial property, Real estate investment trust

HONOLULU, Nov. 15, 2022 /PRNewswire/ --Alexander & Baldwin, Inc. (NYSE:ALEX) (A&B)announced today that its management team will participate in investor meetings at Nareit's REITworld 2022 Annual Conference in San Francisco.

Key Points: 
  • HONOLULU, Nov. 15, 2022 /PRNewswire/ --Alexander & Baldwin, Inc. (NYSE:ALEX) (A&B)announced today that its management team will participate in investor meetings at Nareit's REITworld 2022 Annual Conference in San Francisco.
  • Investor material for the conference, scheduled for November 1517, 2022, may be accessed on the Company's website at www.alexanderbaldwin.com .
  • Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B)is the only publicly-traded real estate investment trust to focus exclusively on Hawai'i commercial real estate and is the state's largest owner of grocery-anchored, neighborhood shopping centers.
  • A&B is expanding and strengthening its Hawai'i CRE portfolio and achieving its strategic focus on commercial real estate by monetizing its remaining non-core assets.

Alexander & Baldwin Announces Third Quarter 2022 Earnings Release and Conference Call Date

Retrieved on: 
Wednesday, October 12, 2022
NYSE, Tourism, CRE, Alexander & Baldwin, Webcast, Transport, Investor, A&B, Alexander, ALEX, Management

HONOLULU, Oct. 12, 2022 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B)will report results for the third quarter 2022, after the market closes, on Thursday, November 3, 2022.

Key Points: 
  • HONOLULU, Oct. 12, 2022 /PRNewswire/ -- Alexander & Baldwin, Inc. (NYSE: ALEX) (A&B)will report results for the third quarter 2022, after the market closes, on Thursday, November 3, 2022.
  • In connection with this announcement, A&B will host a conference call and webcast on Thursday, November 3, 2022, at 5:00 p.m.
  • To listen to the conference call, please dial in at least 5 minutes prior to start time.
  • Presentation slides will be available for download from A&B's website after the market closes on November 3, 2022.